An investigation on behalf of investors in Immune Pharmaceuticals Inc (NASDAQ:IMNP) shares over potential wrongdoing at Immune Pharmaceuticals was announced and NASDAQ:IMNP stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 03/31/2017 -- An investigation was announced for investors in shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) over potential breaches of fiduciary duties by certain directors at Immune Pharmaceuticals Inc.
Investors who purchased shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Immune Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Immune Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology.
Shares of Immune Pharmaceuticals Inc (NASDAQ:IMNP) declined from $5.44 per share in March 2014 to as low as $0.13 per share on March 27, 2017.
Those who purchased shares of Immune Pharmaceuticals Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com